We are actively tracking the number of publications by the scientific community which reference our structures, whether in the main text, figure captions or supplementary material. Selected articles are manually reviewed. Publications by SSGCID authors are excluded from the manually reviewed list. From our manual curation results, we estimate that the false positive rate might be as high as 50% for some structures.
This list was obtained from Google Scholar searches using an API provided by Christian Kreibich.
| Structure | Year released | #citations |
|---|---|---|
| 5SD3 | 2022 | 0 |
| 5SD2 | 2022 | 0 |
| 5SD1 | 2022 | 0 |
| 5SD0 | 2022 | 0 |
| 3L0D | 2009 | 0 |
| 5SCZ | 2022 | 0 |
| 2MYY | 2015 | 0 |
| 2MRL | 2014 | 0 |
| 5SCY | 2022 | 0 |
| 3JS9 | 2009 | 0 |
| # | PDB | Additional SSGCID structures cited | Link | Title | Year | Citation | Highlighted abstract |
|---|---|---|---|---|---|---|---|
| 1 | 6bfu | - | https://www.biorxiv.org/content/10.1101/2020.02.18.955195v1.abstract | Structure and immune recognition of the porcine epidemic diarrhea virus spike protein | 2020 | RN Kirchdoerfer, M Bhandari, O Martini, LM Sewall- bioRxiv, 2020 - biorxiv.org | from HuCoV-NL63 (5SZS. pdb (Walls et al., 2016b)), Porcine deltacoronavirus ( 6BFU . pdb , (Xiong et pdb , (Kirchdoerfer et al., 2018)) and Infectious bronchitis virus (6CV0. pdb , (Shang et the PEDV spike differs in several regards to the previously determined NL63 spike structure |
| 2 | 4ni5 | 4weo, 5jy1 | https://biotechnologyforbiofuels.biomedcentral.com/articles/10.1186/s13068-020-0... | Phylogenetics-based identification and characterization of a superior 2, 3-butanediol dehydrogenase for Zymomonas mobilis expression | 2020 | V Subramanian, VV Lunin- Biotechnology, 2020 - biotechnologyforbiofuels | Zymomonas mobilis has recently been shown to be capable of producing the valuable platform biochemical, 2,3-butanediol (2,3-BDO). Despite this capability, the production of high titers of 2,3-BDO is restricted by several physiological parameters. ... The initial model was built based on PDB entry 4ni5 with FFAS03 search and ProtMod modeling servers [50,51,52] using the SCWRL method. |
| 3 | 3hgb | - | https://www.frontiersin.org/articles/10.3389/fbioe.2020.00965/full?report=reader | Mechanism-driven metabolic engineering for bio-based production of free R-lipoic acid in Saccharomyces cerevisiae mitochondria | 2020 | B Chen, JL Foo, H Ling, MW Chang- Frontiers in bioengineering and, 2020 - frontiersin.org | is glycine cleavage system protein H from Mycobacterium tuberculosis ( PDB chain id: 3hgb .1.A domains) were modeled due to the lack of templates with crystal structure of full acetyltransferase component of the pyruvate dehydrogenase complex in Homo sapiens ( PDB |
| 4 | 4g6c | - | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744477/ | New Putative Antimicrobial Candidates: In silico Design of Fish-Derived Antibacterial Peptide-Motifs | 2020 | H Okella, JJ Georrge, S Ochwo, C Ndekezi- Frontiers in, 2020 - ncbi.nlm.nih.gov | a global docking procedure in four folds, motif-based prediction based on peptide conformation, rigid-body docking, scoring based on structural clustering; and final structure minimization. ... The affinity of peptide-motifs A15_B and A15_E was highest within chains of the target proteins (PDB ID 1rrv, 4g6c, and 4oj8). |
| 5 | 6tz8 | - | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669531/ | Current Challenges and Opportunities in Designing ProteinProtein Interaction Targeted Drugs | 2020 | WH Shin, K Kumazawa, K Imai- and Applications in, 2020 - ncbi.nlm.nih.gov | Phase Reached*, Modality*, Drug PDB ID**, Drug-Protein PDB ID*, Target PPI PDB ID binding protein 1A inhibitor, Inhibitor, Approved (1994), Small molecule, FK5, 1BKF, 6TZ8 (FKBP12/CNA 2.8 resolution by cryo-electron microscopy (cryo-EM).65 The cryo-EM structure revealed ... 6TZ8 (FKBP12/CNA/CNB) (C. neoformans) |
| 6 | 6q05 | - | https://arxiv.org/abs/2002.06196 | Structural modeling of 2019-novel coronavirus (nCoV) spike protein reveals a proteolytically-sensitive activation loop as a distinguishing feature compared to SARS | 2020 | JA Jaimes, NM Andre, JK Millet- arXiv preprint arXiv, 2020 - arxiv.org | Protein Data Base: HCoV-HKU1 ( PDB # 5I08), MHV ( PDB # 3JCL), MERS-CoV ( PDB # 6Q05 ), SARS-CoV ( PDB # 5X58), FCoV-UU4 ( PDB # 6JX7), IBV-M41 ( PDB # 6CV0) and HCoV-NL63 ( PDB # 5SZS). Pairwise S structure . Additional |
| 7 | 6q05 | - | https://www.journal.atmph-specialissues.org/uploads/179/8422_pdf.pdf | A Review of Current Literature on sudden Upsurge of COVID-19 | 2020 | R Sharma- Annals of Tropical Medicine and Public, 2020 - journal.atmph-specialissues.org | 6Q05 MERSCoV S structure in complex with SialylLewis Available from: http://www.rcsb.org/ pdb /results/results.do?tabtoshow=Unreleased and qrid=7E90BED0 coronavirus papain-like novel protease inhibitors: Design, synthesis, protein-ligand X-ray structure and biological |
| 8 | 5j3b | - | https://www.sciencedirect.com/science/article/pii/S2211124720303089 | Structure and Function of an Elongation Factor P Subfamily in Actinobacteria | 2020 | B Pinheiro, CM Scheidler, P Kielkowski, M Schmid- Cell Reports, 2020 - Elsevier | In order to gain insights into the structural configuration of this Actinobacteria EF-P, we X-ray crystal structure to 2.2- resolution (for data processing and structure refinement statistics its overall folding topology with the previously reported bacterial EF-P structures and consists of |
| 9 | 5j3b | - | https://www.sciencedirect.com/science/article/pii/S0969212620303737 | Structural Basis for Toxin Inhibition in the VapXD Toxin-Antitoxin System | 2020 | MB Bertelsen, M Senissar, MH Nielsen, F Bisiak- Structure, 2020 - Elsevier | Here, we provide structural insights into the architecture of the intact VapXD TA complex and toxin residues missing in each chain likely due to flexibility (Figure S1A). The structure consists of PDB Entry, VapXD (Selenomethionine) 6ZN8, VapD (Wild Type) 6ZI0, VapD (D7N) 6ZI1... (B) Structure of the Acinetobacter baumannii EF-P OB fold with conserved secondary structure in gold (PDB: 5J3B, left) and corresponding topology (right). |
| 10 | 3eiy | - | https://arxiv.org/abs/2012.05716 | Utilising Graph Machine Learning within Drug Discovery and Development | 2020 | T Gaudelet, B Day, AR Jamasb, J Soman- arXiv preprint arXiv, 2020 - arxiv.org | and evolve along a temporal dimension resulting in changes to composition, structure and attributes One such approach is to use a graph's structural information to regularise embeddings authors suggest the atten- tion mechanism is decoupled from the architecture and should |